Form 4 for OPRX OptimizeRx Corp
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001213900-21-048613 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-17 | 2021-09-15 | OPRX | FEBBO WILLIAM J | CEO, Dir | S - Sale | $65.74 | -16.7K | 519.4K | -3% | -$1.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-09-15 | S | D | 16,666 | $65.74 | 519,375 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |